Autoimmunity in differentiated thyroid cancer: significance and related clinical problems.
about
Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies.Increased prevalence of chronic lymphocytic thyroiditis in Korean patients with papillary thyroid cancer.Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paperBRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration.How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodiesHashimoto's thyroiditis: similar and dissimilar characteristics in neighboring areas. Possible implications for the epidemiology of thyroid cancer.Biomarkers of thyroid function and autoimmunity for predicting high-risk groups of thyroid cancer: a nested case-control studyAssociation between benign thyroid and endocrine disorders and subsequent risk of thyroid cancer among 4.5 million U.S. male veterans.Some clinical aspects in chronic autoimmune thyroiditis associated with thyroid differentiated cancer.Coexistence of papillary thyroid cancer with Hashimoto thyroiditis.Metastatic malignant struma ovarii with coexistence of Hashimoto's thyroiditis.Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer?Radiation-induced inflammation and autoimmune diseases.Incidental thyroid carcinoma in surgery-treated hyperthyroid patients with Graves' disease: a systematic review and meta-analysis of cohort studies.
P2860
Q33594636-8239D3DD-3C5A-4389-8C80-F5DFFCDB31C2Q33753861-06BF5525-7F57-4DD1-9EBD-B956F79748F0Q33825202-D830631D-36A8-467A-809D-1131943BE2FAQ34103836-553B6DB7-BE8A-4C42-B94F-651EB0114D0DQ34134307-CBB5E3CC-D16E-43A4-BEC0-9B73C5C43862Q34633929-384EC999-4E7E-44E1-A942-206DF9DC96CAQ34895975-A208302B-C6EB-407F-80CA-35F245DBCE20Q36134726-0E25C420-C474-4636-BFDE-3751639AC97CQ36671262-262DDEFF-3C18-407F-90FE-70E039084869Q36683931-F83B192F-234D-4683-BD18-CE1B05A293ABQ36923537-510AC6E6-F266-4AFD-9980-D755F79EBD72Q37460181-2E5813D5-92F2-4BE8-AB9F-D240AA1ACA15Q45359756-F3ED37F2-F655-4104-A08C-06D06BBBB56BQ53176987-9CAEA1C0-CB2F-4848-90DC-2B9F300A7AA6Q55427690-30CD5306-4741-441F-B5D0-E22D7B52294E
P2860
Autoimmunity in differentiated thyroid cancer: significance and related clinical problems.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autoimmunity in differentiated ...... and related clinical problems.
@en
Autoimmunity in differentiated ...... and related clinical problems.
@nl
type
label
Autoimmunity in differentiated ...... and related clinical problems.
@en
Autoimmunity in differentiated ...... and related clinical problems.
@nl
prefLabel
Autoimmunity in differentiated ...... and related clinical problems.
@en
Autoimmunity in differentiated ...... and related clinical problems.
@nl
P1476
Autoimmunity in differentiated ...... and related clinical problems.
@en
P2093
Ase Krogh Rasmussen
Ulla Feldt-Rasmussen
P304
P577
2010-04-01T00:00:00Z